We’ve added a few papers to the Papers page. The most important application result is our work on GPCR intermediates as new possible drug targets. We also have several new methodological advances which are proving important for our work going on right now.
Coming up (hopefully) soon will be a paper on new drug targets involving kinases, key protein targets involved in fighting cancer.